English | Español
Patient Daily | Feb 22, 2026

Ocular Therapeutix’s hydrogel shows stronger results than Eylea in late-stage wet AMD trial
Patient Daily | Feb 22, 2026

Vaxart advances oral norovirus vaccine as rivals face clinical challenges
Patient Daily | Feb 22, 2026

Compass Pathways reports positive phase 3 results for psilocybin-based depression therapy
Patient Daily | Feb 22, 2026

Disc Medicine faces regulatory uncertainty after FDA rejects rare disease drug
Patient Daily | Feb 22, 2026

Biopharma faces rising costs as fetal bovine serum shortages tighten supplies
Patient Daily | Feb 22, 2026

Radiopharma industry boosts efforts to secure actinium‑225 amid growing demand
Patient Daily | Feb 22, 2026

Eli Lilly licenses CSL’s IL-6 antibody in $100M deal amid acquisition spree
Patient Daily | Feb 22, 2026

JAX-NYSCF partners with GSK to improve models for neurodegenerative disease research

Trending
+ Pharmaceuticals
Patient Daily | May 7, 2026

FARE launches new PSA featuring Joshua Jackson to raise food allergy awareness
Patient Daily reports | May 8, 2026

Columbia Breathe Free patient in 5.0 Google review: ‘I am already feeling like my nose is just moving air better’
+ Pharmaceuticals
Patient Daily | May 7, 2026

Sanofi requests removal of Tzield from CNPV program after Høeg gets involved
+ Regulatory
Patient Daily | May 11, 2026

HEAL Network Director Parente on 340B program: 'Patients often see none of the discount'